Not All Peppers Are Created Equal
Two vials. Same label, same claim, same price. One of them is what it says it is.
Key takeaways
- Identity, purity, and stability are three separate questions. Most quality claims answer at most one of them.
- Transparency is not a tone of voice. It is documents, lot numbers, and named laboratories.
- Price sorts nothing. Cheap material can be well documented and expensive material can be undocumented.
- The realistic goal is not certainty. It is replacing a guess with a much better-informed estimate.
Put two vials side by side. Same compound printed on the label, same stated quantity, same white lyophilised cake at the bottom, same claim of 99% purity, roughly the same price.
One came from a manufacturer that tests every lot at a named accredited laboratory, confirms identity by mass spectrometry alongside purity by HPLC, publishes the full report per lot, and ships in validated packaging. The other came from a reseller who bought a drum, filled some vials, and reused a certificate from a batch that no longer exists.
Nothing you can see distinguishes them. That is not a failure of attention. It is the actual structure of the problem: the things that separate these two vials all happened before the vial reached you, and the only trace they leave is paperwork.
Three questions, not one
The word "quality" collapses at least three separate questions into one syllable, and almost every claim in this market answers no more than one of them.
| Question | What answers it | How often it is answered |
|---|---|---|
| Is it the right molecule? | Mass spectrometry — expected vs observed mass | Frequently skipped entirely |
| How much of the sample is that molecule? | HPLC, with its method stated | Usually claimed, often without method |
| Is it still intact now? | Stability data, storage conditions, cold chain | Almost never addressed |
A supplier can be completely honest and still leave two of the three unanswered. That is the normal case, not the villainous one. The failure most people run into is not fraud — it is the gap between a claim that sounds comprehensive and a claim that is narrow.
What transparency looks like when it is real
Transparency has been reduced to an aesthetic: clean packaging, confident copy, the word itself printed somewhere near the word "premium". None of that is checkable, which is the whole point of it.
The real version is unglamorous and specific:
- Lot-level documents. A certificate that matches the number on your vial, not a representative one.
- A named laboratory. With accreditation you can look up.
- Full reports, not graphics. The chromatogram, the method, the analyst, the date.
- Identity as well as purity. Both questions asked, both answered.
- Results that vary. Real measurement produces variance. Identical figures across every lot are a specification, not a series of results.
- Straight answers to direct questions. How a supplier responds to "can I see the COA for lot X" is itself a data point.
Why the noise persists
This market rewards confident claims and punishes almost nothing. Making a strong statement costs a sentence. Verifying it costs instrument time, laboratory fees, and the risk of a number you did not want. The incentives run one direction.
Meanwhile the vocabulary that would let buyers tell the difference — area percent, net peptide content, deletion sequences, chain of custody — is technical enough that most people never acquire it, and there is very little in the way of plain-English education that is not attached to somebody selling something.
That is the gap this publication exists to work on. Not to tell you which vial to buy. To hand you the questions that make the difference between the two vials visible.
What we are actually claiming
We are not claiming that testing is a guarantee, that documentation is proof, or that a well-run supplier cannot have a bad lot. Every method here has limits, and we would rather write about the limits than pretend they are not there.
What we are claiming is narrower and more defensible: an informed buyer asking five specific questions is in a completely different position from one comparing two labels. Not certain. Better informed. In a market this opaque, that is the achievable win, and it is worth more than any confident number printed on a box.
Know more. Research better.
Sources
We link to primary sources — PubMed, ClinicalTrials.gov, FDA, NIH, peer-reviewed journals, and laboratory documentation. Entries marked needs research are placeholders: the claim in the text is not yet backed by a verified citation and should be read as unconfirmed until it is.
Analytical characterisation requirements for peptide products
FDA / USP
Needs research
Anchor the three-questions framing to a real regulatory characterisation standard.
Got Peppers is owned by the same team as PepGenex and may earn a commission on links to it. That relationship never decides what we publish.